Abstract
IT has been shown that rabbit anti-serum against rat serum (RARS) injected intravenously into rats produces fatal anaphylactic shock1. This was interpreted as a reaction of RARS with γ-globulins adsorbed on the cell surface2. It therefore seemed reasonable to investigate the same effect on enhancing antibodies by injecting RARS into rats bearing Yoshida ascites sarcoma (YAS). The result was as expected–delayed death. It has been suggested that the “de-enhanced” tumour cells become more susceptible to lymphocytes3. Although the presence of enhancing antibodies coating YAS cells has not actually been shown, if they are responsible for the observed phenomena, other agents acting on γ-globulins should result in both anaphylaxis and “de-enhancement”. We therefore used cathepsins isolated from white blood cells, which act specifically on β and γ-globulins4.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
We are sorry, but there is no personal subscription option available for your country.
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Dekaris, D., Intern. Arch. Allergy, 28, 193 (1965).
Humphrey, J. H., and Mota, I., Immunology, 2, 31 (1959).
Allegretti, N., Jurin, M., and Andreis, I., Period. Biol., 72, 75 (1970).
Lebez, D., and Kopitar, M., Enzymologia (in the press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
ALLEGRETTI, N., ANDREIS, I., KOPITAR, M. et al. Cathepsins inhibit Growth of Yoshida Ascites Sarcoma in Rat. Nature New Biology 229, 180–181 (1971). https://doi.org/10.1038/newbio229180a0
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1038/newbio229180a0
